The American Journal of Medicine
Volume 116, Issue 3 , Pages 145-150 , 1 February 2004

Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study

  • Demosthenes B Panagiotakos, PhD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Demosthenes B. Panagiotakos, PhD, 46 Paleon Polemiston St. Glyfada, Attica, 166 74, Greece
    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • Christos Pitsavos, MD, PhD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • Christina Chrysohoou, MD, PhD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • John Skoumas, MD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • Constadina Masoura, MD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • Pavlos Toutouzas, MD, PhD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece
    • ,
  • Christodoulos Stefanadis, MD, PhD

      Affiliations

    • First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece

Received 12 March 2003 ,Revised 24 July 2003 ,Accepted 24 July 2003.

References 

  1. Glantz SA, Parmley WW. Passive smoking and heart disease (mechanisms. and risk). JAMA. 1995;273:1047–1053
  2. Kawachi I, Colditz GA, Speizer F, et al.  A prospective study of passive smoking and coronary heart disease. Circulation. 1997;95:2374–2379
  3. He J, Vupputuri S, Allen K, et al.  Passive smoking and the risk of coronary heart disease (a meta-analysis of epidemiologic studies). N Engl J Med. 1999;340:920–992
  4. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al.  The association between exposure to environmental tobacco smoke and the development of acute coronary syndromes (the CARDIO2000 case-control study). Tob Control. 2002;11:220–225
  5. Glantz S, Parmley WW. Passive smoking and heart disease (epidemiology, physiology, and biochemistry). Circulation. 1991;83:1–12
  6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  7. Pitsavos C, Chrysohoou C, Panagiotakos DB, et al.  Association of leisure-time physical activity on inflammation markers (C-reactive protein, white-blood cell count, serum amyloid-A and fibrinogen), in healthy subjects (from the ATTICA study). Am J Cardiol. 2003;91:368–370
  8. Willett WC, Sacks F, Trichopoulou A, et al.  Mediterranean diet pyramid (a cultural model for healthy eating). Am J Clin Nutr. 1995;61(suppl):1402S–1406S
  9. Smoke Free Workplaces, Improving the Health and Well Being of People at Work. Brussels, Belgium: European Status Report; 2001
  10. Garland C, Barrett-Connor E, Suarez L, et al.  Effects of passive smoking on ischemic heart disease mortality of nonsmokers (a prospective study). Am J Epidemiol. 1985;121:645–650
  11. Steenland K, Thun M, Lally C, Heath C. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 1996;94:622–628
  12. Kritz H, Schmid P, Sinzinger H. Passive smoking and cardiovascular risk. Arch Intern Med. 1995;155:1942–1948
  13. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med. 1989;149:386–389
  14. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation. 1998;97:2012–2016
  15. Wood D. Recent advances in cardiology (established and emerging cardiovascular risk factors). Am Heart J. 2001;141(suppl):S49–S57
  16. Haverkate F, Thompson SG, Pyke SD, et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet. 1997;349:461–466
  17. Yarnell JWG, Baker IA, Sweetman PM, et al.  Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart diseases (the Caerphilly and Speewell collaborative heart disease studies). Circulation. 1991;83:836–844
  18. Evans RW, Shaten BJ, Hempel JD, et al.  Homocysteine and risk of cardiovascular disease in Multiple Risk Factor Interventional Trial. Arterioscler Thromb Vasc Biol. 1997;17:1947–1953
  19. Iso H, Shimamoto T, Sato S, Koike K, Lida M, Komachi Y. Passive smoking and fibrinogen concentrations. Am J Epidemiol. 1996;144:1151–1154
  20. Brownson RC, Alavanja MCR, Hock ET. Reliability of passive smoke exposure histories in a case-control study of lung cancer. Int J Epidemiol. 1993;22:804–808
  21. Coultas DB, Peake GT, Samet JM. Questionnaire assessment of lifetime and recent exposure to environmental tobacco smoke. Am J Epidemiol. 1989;130:338–347
  22. Pron GE, Burch JD, Howe GR, Miller AB. The reliability of passive smoking histories reported in a case-control study of lung cancer. Am J Epidemiol. 1988;127:267–273
  23. Meade TW, Mellows S, Brozovic M, et al.  Haemostatic function and ischemic heart disease (principal results of the Northwick Park Heart Study). Lancet. 1986;230:533–537

☆ The ATTICA study was supported by research grants from the Hellenic Cardiological Society (HCS2002) and the Hellenic Atherosclerosis Society (HAS2003).

PII: S0002-9343(03)00656-9

doi: 10.1016/j.amjmed.2003.07.019

The American Journal of Medicine
Volume 116, Issue 3 , Pages 145-150 , 1 February 2004

Article Tools